News & Event

Register for news & events
Loading
News background
News icon

14/08/2020

RevitalVision recieves R&D grant from the Israeli Innovation Authority

News icon

01/08/2020

WSPOS – World Wide Webinar on Amblyopia – Sponsored by REVITALVISION

News icon

2020

A New Adult Amblyopia study presented at AIOS 2020 (All India Ophthalmology Society)

meeting 2020 confirming again the efficacy of RevitalVision in improving vision in adult amblyopia

Download ppt
AIOS 2020
News icon

7 October

REVITALVISION will participate at the upcoming AAOPT (AMERICAN ACADEMY of OOPTOMETRY)

Meeting in Nashville, TN, USA 7-10 October

Link to article
AAOPT
News icon

21-24 April 2021

REVITALVISION will participate at the upcoming 41st ESA (EUROPEAN STRABISMOLOGICAL ASSOCIATION)

Meeting in PARIS 21th /24th April 2021

Link to article
ESA
News icon

2020

Tel Aviv Medical Center is recruiting Age related Macular Degeneration patients for a REVITALVISION clinical study

A Proof-of-Concept, Prospective, Open label, Randomized Clinical Study Evaluating RevitalVision® Therapy for Improving Best Corrected Visual Acuity (BCVA) and Contrast Sensitivity Function (CSF) in Patients Suffering from stabler Age related Macular Degeneration (AMD)

Contact Us

Talshir Medical Technologies LTD
Hama’ayan Street 2, Modi’in 7177871, Israel
USA Office: +1.785.856.0417 | Main Office: +972.77.212.3272

info@revitalvision.com
Contact background